Phillip Scheinberg, MD

Articles by Phillip Scheinberg, MD

Phillip Scheinberg, MDMyelodysplastic Syndromes | December 14, 2023

Dr. Schienberg discussed luspatercept in MDS, selinexor in AML, and the difficulty of randomizing trials.

Phillip Scheinberg, MDMyelodysplastic Syndromes | September 11, 2023

"There's been a lot of focus on classifications and mutations: they're coming with a lot of force," Dr. Scheinberg said.

Chadi Nabhan, MD, MBA, FACPMeeting News | January 10, 2023

Phillip Scheinberg, MD, talk about CHIP and the IPSS-M in MDS with Chadi Nabhan, MD, host of The HemOnc Pulse, during ASH.